Unmet Health Needs for Patients With Uveal Melanoma

Share this content:
Unmet Health Needs for Patients With Uveal Melanoma
Unmet Health Needs for Patients With Uveal Melanoma

FRIDAY, March 2, 2018 (HealthDay News) -- Most patients with uveal melanoma have unmet health information and psychological needs, according to a study published online Feb. 22 in JAMA Ophthalmology.

Timothy J. Williamson, M.P.H., from the University of California, Los Angeles, and colleagues conducted a longitudinal survey study at a university-based ophthalmology practice from June 1, 2007, to July 1, 2011, involving 107 patients diagnosed with uveal melanoma by an ophthalmologist. The Cancer Needs Questionnaire was used to assess unmet needs (desire for help in psychological, physical, health information, communication, or social domains).

The researchers found that 99 percent of patients expressed at least one unmet need at one week after diagnosis and 86 percent did so three months later. Needs in the health information and psychological domains were most frequently endorsed. Over three months there was a significant decline in patients' unmet needs. There was no correlation for sociodemographic and medical characteristics with unmet need severity. Lower unmet need severity at one week after diagnosis was predicted by higher prediagnosis instrumental social support and lower neuroticism. Lower unmet need severity three months after diagnosis and a decline in needs from diagnosis to three months later were predicted by having a smaller social network.

"These findings suggest that prior to or at diagnosis, the severity of such needs and psychosocial factors that may be associated can be identified for proactive supportive intervention," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »